{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:45:30Z","timestamp":1760150730352,"version":"build-2065373602"},"reference-count":47,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Pregestational and gestational diabetes mellitus are relevant complications of pregnancy, and antidiabetic drugs are prescribed to obtain glycemic control and improve perinatal outcomes. The objective of this study was to describe the prescription pattern of antidiabetics before, during and after pregnancy in Italy and to evaluate its concordance with the Italian guideline on treatment of diabetes mellitus. A multi-database cross-sectional population study using a Common Data Model was performed. In a cohort of about 450,000 women, the prescribing profile of antidiabetics seemed to be in line with the Italian guideline, which currently does not recommend the use of oral antidiabetics and non-insulin injection, even if practice is still heterogeneous (up to 3.8% in the third trimester used oral antidiabetics). A substantial variability in the prescription pattern was observed among the Italian regions considered: the highest increase was registered in Tuscany (4.2%) while the lowest was in Lombardy (1.5%). Women with multiple births had a higher proportion of antidiabetic prescriptions than women with singleton births both in the preconception period and during pregnancy (1.3% vs. 0.7%; 3.4% vs. 2.6%) and used metformin more frequently. The consumption of antidiabetics in foreign women was higher than Italians (second trimester: 1.8% vs. 0.9%, third trimester: 3.6% vs. 1.8%).<\/jats:p>","DOI":"10.3390\/ijerph20237139","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T12:15:14Z","timestamp":1701692114000},"page":"7139","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antidiabetic Therapy during Pregnancy: The Prescription Pattern in Italy"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-4776","authenticated-orcid":false,"given":"Anna","family":"Locatelli","sequence":"first","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Pergolesi 33, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6898-7217","authenticated-orcid":false,"given":"Sara","family":"Ornaghi","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Pergolesi 33, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Terzaghi","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Pergolesi 33, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-443X","authenticated-orcid":false,"given":"Valeria","family":"Belleudi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Lazio Regional Health Service, ASL Roma 1, 00147 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6587-9808","authenticated-orcid":false,"given":"Filomena","family":"Fortinguerra","sequence":"additional","affiliation":[{"name":"Italian Medicines Agency (AIFA), 00187 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Poggi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Lazio Regional Health Service, ASL Roma 1, 00147 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Perna","sequence":"additional","affiliation":[{"name":"Italian Medicines Agency (AIFA), 00187 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-8484","authenticated-orcid":false,"given":"Francesco","family":"Trotta","sequence":"additional","affiliation":[{"name":"Italian Medicines Agency (AIFA), 00187 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"MoM-Net Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"ref_1","unstructured":"(2023, March 15). Diabetes Mellitus and Pregnancy: Clinical Guideline. Directorate of Women\u2019s Health Ministry of Health-Trinidad and Tobaco, Available online: https:\/\/www.health.gov.tt\/sites\/default\/files\/womenshealth\/20181121-Womens-Health-diabetes-mellitus.pdf."},{"key":"ref_2","unstructured":"NICE (2023, February 22). Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. NICE Guideline. Published: 25 February 2015; Last updated: 16 December 2020. Available online: https:\/\/www.nice.org.uk\/guidance\/ng3."},{"key":"ref_3","unstructured":"Linea-Guida Gravidanza Fisiologica (2023, March 03). Aggiornamento 2011. Diagnosi del Diabete Gestazionale, pp. 169\u2013173, Available online: https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_1436_allegato.pdf."},{"key":"ref_4","unstructured":"Associazione Medici Diabetologi (AMD), and Societ\u00e0 Italiana di Diabetologia (SID) (2020, July 27). Standard Italiani per la Cura del Diabete Mellito 2018. Available online: https:\/\/aemmedi.it\/wp-content\/uploads\/2009\/06\/AMD-Standard-unico1.pdf."},{"key":"ref_5","unstructured":"ISS (2023, March 15). Diabete Gestazionale. 2020. Rome, 2023, Available online: https:\/\/www.salute.gov.it\/portale\/donna\/dettaglioContenutiDonna.jsp?id=4493&area=Salute%20donna&menu=patologie."},{"key":"ref_6","unstructured":"Centers for Disease Control and Prevention (2023, May 22). Gestational Diabetes, Available online: http:\/\/www.cdc.gov\/diabetes\/basics\/gestational.html."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-159-2-201307160-00661","article-title":"Benefits and Harms of Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research","volume":"159","author":"Hartling","year":"2013","journal-title":"Ann Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Crowther, C.A., Samuel, D., Hughes, R., Tran, T., Brown, J., Alsweiler, J.M., and on behalf of the TARGET Study Group (2022). Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial. PLoS Med., 19.","DOI":"10.1371\/journal.pmed.1004087"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e067946","DOI":"10.1136\/bmj-2021-067946","article-title":"Gestational diabetes mellitus and adverse pregnancy outcomes: Systematic review and meta-analysis","volume":"377","author":"Ye","year":"2022","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2020). Management of diabetes in pregnancy: Standards of medical care in Diabetes-2020. Diabetes Care, 43, S183\u2013S192.","DOI":"10.2337\/dc20-S014"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s13300-020-00865-3","article-title":"American Diabetes Association \u201cStandards of Medical Care\u20142020 for Gestational Diabetes Mellitus\u201d: A Critical Appraisal","volume":"11","author":"Goyal","year":"2020","journal-title":"Diabetes Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Harrison, R.K., Cruz, M., Wong, A., Davitt, C., and Palatnik, A. (2020). The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus. BMC Pregnancy Childbirth, 20.","DOI":"10.1186\/s12884-020-03449-y"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/14767058.2020.1711728","article-title":"Maternal racial and ethnic disparities in glycemic threshold for pharmacotherapy initiation for gestational diabetes","volume":"35","author":"Palatnik","year":"2020","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9804708","DOI":"10.1155\/2019\/9804708","article-title":"Comparative efficacy and safety of metformin, glyburide and insulin in treating gestational diabetes mellitus: A meta-analysis","volume":"2019","author":"Guo","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_16","first-page":"CD012037","article-title":"Insulin for the treatment of women with gestational diabetes (review)","volume":"11","author":"Brown","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_17","first-page":"CD011967","article-title":"Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes (review)","volume":"1","author":"Brown","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_18","unstructured":"American Congress of Obstetricians and Gynecologists (2018). Gestational Diabetes Mellitus, ACOG. ACOG Practice Bulletin."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"(2023). Summary of Revisions: Standard of Care in Diabetes-2023. Diabetes Care, 46, S5\u2013S9.","DOI":"10.2337\/dc23-Srev"},{"key":"ref_20","unstructured":"(2018). SMFM Statement: Pharmacological Treatment of Gestational Diabetes, Elsevier."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0020-7292(15)30007-2","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care","volume":"131","author":"Hod","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_22","unstructured":"AIFA (2023, September 15). Gazzetta Ufficiale della Repubblica Italiana. Anno 163\u00b0-numero291. Rome, 14 December 2022. Available online: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2022\/12\/14\/291\/sg\/pdf."},{"key":"ref_23","unstructured":"AIFA\u2014Agenzia Italiana del Farmaco (2023, September 15). Modifica Dell\u2019autorizzazione All\u2019immissione in Commercio del Medicinale per uso Umano, a Base di Metformina Cloridrato, <<Glucophage>>. Available online: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2022\/10\/18\/244\/sg\/pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e002363","DOI":"10.1136\/bmjdrc-2021-002363","article-title":"Metformin in pregnancy and risk of adverse long-term outcomes: A register-based cohort study","volume":"10","author":"Brand","year":"2022","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.2337\/dc22-S015","article-title":"Management of diabetes in pregnancy: Standards of medical care in diabetes\u20142022","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00592-023-02137-5","article-title":"Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID) and the Italian Study Group of Diabetes in pregnancy: Metformin use in pregnancy","volume":"60","author":"Sciacca","year":"2023","journal-title":"Acta Diabetol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ventura, M., Maraschini, A., D\u2019aloja, P., Kirchmayer, U., Lega, I., Davoli, M., and Donati, S. (2018). Drug prescribing during pregnancy in a central region of Italy, 2008\u20132012. BMC Public Health, 18.","DOI":"10.1186\/s12889-018-5545-z"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: A population-based study in Regione Emilia-Romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Navaro, M., Vezzosi, L., Santagati, G., Angelillo, I.F., and Collaborative Working Group (2018). Knowledge, attitudes, and practice regarding medication use in pregnant women in Southern Italy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198618"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cpt.1833","article-title":"Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European Model","volume":"108","author":"Gini","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/cpt.1577","article-title":"Choosing Among Common Data Models for Real-World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products","volume":"107","author":"Schneeweiss","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"699062","DOI":"10.3389\/fphar.2021.699062","article-title":"The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives","volume":"12","author":"Belleudi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fortinguerra, F., Belleudi, V., Poggi, F.R., Perna, S., Bortolus, R., Donati, S., D\u2019aloja, P., Da Cas, R., Clavenna, A., and Locatelli, A. (2023). Monitoring medicine prescriptions before, during and after pregnancy in Italy. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0287111"},{"key":"ref_34","unstructured":"(2023, November 19). Salute Della Popolazione Straniera. Rapporto Osservsalute 2017. Available online: https:\/\/www.osservatoriosullasalute.it\/wp-content\/uploads\/2018\/04\/ro-2017-arg-popolazione_straniera.pdf."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"D\u2019aloja, P., Da Cas, R., Belleudi, V., Fortinguerra, F., Poggi, F.R., Perna, S., Trotta, F., Donati, S., and MoM-Net Group (2022). Drug Prescriptions among Italian and Immigrant Pregnant Women Resident in Italy: A Cross-Sectional Population-Based Study. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19074186"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Charlton, R.A., Klungs\u00f8yr, K., Neville, A.J., Jordan, S., Pierini, A., de Jong-van den Berg, L.T., Bos, H.J., Puccini, A., Engeland, A., and Gini, R. (2016). Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155737"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lende, M., and Rijhsinghani, A. (2020). Gestational Diabetes: Overview with Emphasis on Medical Management. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17249573"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"517.e1","DOI":"10.1016\/j.ajog.2021.04.229","article-title":"Metformin for gestational diabetes study: Metformin vs insulin in gestational diabetes: Glycemic control and obstetrical and perinatal outcomes: Randomized prospective trial","volume":"225","author":"Olveira","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamapediatrics.2018.4214","article-title":"Association of long-term child growth and developmental outcomes with metformin vs insulin treatment for gestational diabetes","volume":"173","author":"Landi","year":"2018","journal-title":"JAMA Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(23)00004-9","article-title":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy kids): A 24-month follow-up of the MiTy randomized controlled trial","volume":"11","author":"Feig","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): A multicentre, international, randomized, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Owen, M.D., Baker, B.C., Scott, E.M., and Forbes, K. (2021). Interaction between Metformin, Folate and Vitamin B12 and the potential impact on fetal growth and long-term metabolic health in diabetic pregnancies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115759"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajog.2021.04.263","article-title":"Current practices in gestational diabetes mellitus diagnosis and management in the United States: Survey of a maternal-fetal medicine specialists","volume":"225","author":"Davitt","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_44","unstructured":"National Institute for Health and Care Excellence (UK) (2019). Twin and Triplet Pregnancy NICE Guideline [NG137], NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng137."},{"key":"ref_45","first-page":"CD012327","article-title":"Treatments for women with gestational diabetes mellitus: An overview of Cochrane systematic reviews","volume":"8","author":"Martis","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcjd.2019.05.004","article-title":"Ethnicity and Immigration Status as Risk Factors for Gestational Diabetes Mellitus, Anemia and Pregnancy Outcomes Among Food Insecure Women Attending the Montreal Diet Dispensary Program","volume":"44","author":"Sotunde","year":"2020","journal-title":"Can. J. Diabetes"},{"key":"ref_47","unstructured":"Andretta, M., Cinconze, E., Costa, E., Da Cas, R., Geraci, S., Rossi, E., Tognoni, G., and Traversa, G. (2013). Farmaci e Immigrati. Rapporto sulla Prescrizione Farmaceutica in un Paese Multietnico, Il Pensiero Scientifico Editore."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/20\/23\/7139\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:37:45Z","timestamp":1760132265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/20\/23\/7139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":47,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["ijerph20237139"],"URL":"https:\/\/doi.org\/10.3390\/ijerph20237139","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2023,12,4]]}}}